Outcomes and toxicity in patients treated with bimodality or trimodality therapy for esophageal carcinoma with intensity modulated radiation therapy (IMRT).
Ajay Patel(Jacksonville College), Steven J. Buskirk(Mayo Clinic in Florida), Emily Brennan(Editas Medicine (United States)), Michael G. Heckman(Mayo Clinic in Florida), William G. Rule(Mayo Clinic in Arizona), Laura A. Vallow(Jacksonville College), Stephen Ko(Mayo Clinic in Florida), Christopher L. Hallemeier(Mayo Clinic in Arizona), Jonathan B. Ashman(Mayo Clinic in Arizona), Robert C. Miller(Mayo Clinic), Sarah E. James(Mayo Clinic), Jennifer Peterson(Harvard University), C. Hobbs(Mayo Clinic in Florida), Katherine S. Tzou(Jacksonville College)
Cited by 0
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
|The Lancet Neurology|2011|344
Testicular Cancer Survivorship: Research Strategies and Recommendations
|JNCI Journal of the National Cancer Institute|2010|289